BSE filing, NSE: MUNCAPM. Summary written from the filing by ALFA Finder's alert engine.
Munoth Capital Market Ltd: key numbers
- Share price
- ₹104.00
- Market cap
- ₹95.33 Cr
- Revenue (annual)
- ₹0.55 Cr
- Net profit (annual)
- ₹-0.18 Cr
- P/E (TTM)
- -974.7×Sector 19.7×
- Promoter holding
- 73.09%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Munoth Capital Market Ltd
All →Munoth Capital Market Other Announcement
Munoth Capital Markets Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Munoth Capital Market Management Change
Munoth Capital Market appointed Mr. Himanshu Pal as Company Secretary and Compliance Officer, effective October 6, 2026, following Ms. Disha Jay Barot's resignation.
Munoth Capital Market Annual General Meeting
Munoth Capital Markets Ltd concluded its 40th Annual General Meeting on September 30, 2026. Key resolutions included adopting financial statements and approving related party transactions.
Munoth Capital Market Other Announcement
Munoth Capital Markets Ltd will close its share transfer books from 23rd September, 2026 to 30th September, 2026, for the company's 40th Annual General Meeting.
Munoth Capital Market Management Change
Munoth Capital Market Limited announced the resignation of Ms. Varsha Aakesh Gulecha as Non-Executive Independent Director and the appointment of Mr. Vipulkumar Vitthalbhai Patel.
Munoth Capital Market Annual General Meeting
Munoth Capital Market Limited submitted its Annual Report for the financial year 2025-26, including the notice for the upcoming 40th Annual General Meeting.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.